Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Horm Metab Res ; 49(12): 943-950, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29202493

ABSTRACT

The aim of this review was to determine the impact of primary aldosteronism on health-related quality of life (HRQoL) and mental health. We performed a systematic literature search up to July 2017 in six electronic databases. First, we screened the articles derived from this search based on title and abstract. Second, the selected studies were systematically reviewed and checked for our predefined inclusion criteria. The search yielded 753 articles, of which 15 studies met our inclusion criteria. Untreated patients with primary aldosteronism showed an impaired physical and mental HRQoL as compared to the general population. Multiple domains of HRQoL were affected. This applied to patients with both an aldosterone-producing adenoma and bilateral adrenal hyperplasia. Adrenalectomy improves HRQoL. Conflicting results have been reported on the extent of this improvement, the improvement after initiation of medical treatment, and whether there is a difference in HRQoL after both treatments. Similarly, psychopathological symptoms of anxiety, demoralization, stress, depression and nervousness were more frequently reported in untreated patients with primary aldosteronism than in the general population and patients with hypertension. Also an impaired sleep quality has been reported. Improvement of these symptoms was observed after treatment with both adrenalectomy and mineralocorticoid receptor antagonists. This review shows that HRQoL is impaired and psychopathology is more frequently reported in patients with primary aldosteronism. This seems to be at least partly reversible after treatment but the extent of improvement remains unknown. To assess HRQoL in these patients more precisely a primary aldosteronism-specific HRQoL questionnaire is required.


Subject(s)
Health Status , Hyperaldosteronism/physiopathology , Hyperaldosteronism/psychology , Mental Health , Quality of Life , Adenoma/epidemiology , Adenoma/psychology , Adrenal Cortex Neoplasms/epidemiology , Adrenal Cortex Neoplasms/psychology , Adrenal Glands/pathology , Aldosterone/blood , Humans , Hyperaldosteronism/diagnosis , Hyperaldosteronism/epidemiology , Hyperplasia/epidemiology , Hyperplasia/psychology
2.
Int Braz J Urol ; 41(6): 1108-15, 2015.
Article in English | MEDLINE | ID: mdl-26742968

ABSTRACT

PURPOSE: To analyze the association of marital status and survival of patients with ACC using a population-based database. MATERIAL AND METHODS: Patients with ACC were abstracted from the Surveillance Epidemiology and End Results (SEER) database from 1988-2010 (n=1271). Variables included marital status (married vs single/divorced/widowed (SDW)), gender, age, race, tumor (T) and node (N) classification, receipt of surgery, and SEER stage. Statistical analysis was performed using Cox proportional hazard models to generate hazard ratios and 95% confidence intervals. RESULTS: There were 728 (57.3%) females and median age was 56 years (IQR 44-66). Patients who were alive were more frequently married (65.6% vs 61.6%, p=0.008), female (61.1% vs 58.0%, p=0.001), younger (median 51 vs 57 years, p=0.0001), submitted to adrenalectomy (88.6% vs 63.8%, p<0.0001), and more favorable SEER stage (localized- 64.9% vs 29.9%; regional-25.1% vs 30.1%; distant 4.8% vs 31.5%, p<0.0001) compared to patients dead of disease (DOD). On multivariable analysis, factors significantly associated with all-cause mortality were SDW status (HR 1.28, 95% CI 1.09-1.51), age, non-operative management, and N+ disease. Risk factors for disease-specific mortality included SDW status (HR 1.30, 95% CI 1.07-1.56), age, non-operative management, T-classification, and N+ disease. CONCLUSIONS: Marital status is significantly associated with survival in patients with ACC. Our results suggest that the decreased survival seen among SDW individuals highlights an area for further research and needed intervention to reduce disparity.


Subject(s)
Adrenal Cortex Neoplasms/mortality , Adrenocortical Carcinoma/mortality , Marital Status/statistics & numerical data , Adrenal Cortex Neoplasms/psychology , Adrenocortical Carcinoma/psychology , Adult , Aged , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Proportional Hazards Models , Risk Factors , SEER Program , Sex Distribution , United States/epidemiology
3.
J Pediatr Endocrinol Metab ; 29(11): 1313-1317, 2016 Nov 01.
Article in English | MEDLINE | ID: mdl-27771624

ABSTRACT

Adrenocortical carcinoma (ACC) is a rare malignancy in childhood. Affected children with ACC mostly present with virilization, but not the pure form of Cushing's syndrome. A 9-year-old Japanese girl was hospitalized, because of the unstable emotions and excessive weight gain. She was diagnosed as having Cushing's syndrome and a left adrenal tumor. The adrenalectomy led to the pathological diagnosis of ACC without metastasis. There was no mutation of PRKACA in the tumor-derived DNA, or p53 in peripheral blood-derived DNA. Testosterone and dehydroepiandrosterone sulfate (DHEA-S) levels were normal throughout the clinical course. On the other hand, these levels were elevated in all five reported cases of preadolescent ACC children with isolated Cushing's syndrome. The exceptional secretory behavior of ACC gave a diagnostic precaution of the rare pediatric cancer.


Subject(s)
Adrenal Cortex Neoplasms/diagnostic imaging , Adrenal Glands/diagnostic imaging , Adrenocortical Carcinoma/diagnostic imaging , Adrenal Cortex Neoplasms/metabolism , Adrenal Cortex Neoplasms/psychology , Adrenal Cortex Neoplasms/surgery , Adrenal Glands/surgery , Adrenalectomy , Adrenocortical Carcinoma/metabolism , Adrenocortical Carcinoma/psychology , Adrenocortical Carcinoma/surgery , Affective Symptoms/etiology , Affective Symptoms/prevention & control , Androgens/blood , Child , Cushing Syndrome/diagnosis , Diagnosis, Differential , Female , Humans , Hyperphagia/etiology , Hyperphagia/prevention & control , Japan , Treatment Outcome
4.
J Clin Endocrinol Metab ; 97(9): E1640-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22761462

ABSTRACT

CONTEXT: Cognitive function is impaired in patients with active Cushing's syndrome (CS). OBJECTIVE: The aim was to study cognitive function in patients with CS in long-term remission. DESIGN: We conducted a cross-sectional, case-controlled, single center study. PATIENTS: Fifty-five patients previously treated for Cushing's disease (n = 43) and cortisol-producing adrenal adenoma (n = 12) and 55 controls matched for age, gender, and educational level participated in the study. METHODS: Working memory, attention, information-processing speed, verbal fluency, and reading speed were studied using standardized neuropsychological testing and alerting, orienting, and executive control using the Attentional Network Test. Fatigue impact scale and the comprehensive psychopathological rating scale were used to evaluate fatigue and affective disorder. RESULTS: Median (interquartile range) duration of remission was 13 (5-19) yr and the mean ± SD age at follow-up was 54 ± 14 yr. Compared to controls, patients had a higher score on the fatigue impact scale, indicating greater burdens of fatigue, and a higher score on the comprehensive psychopathological rating scale subscales for depression and anxiety. In a multivariate analysis, attention, spatial orienting, alerting, working memory, verbal fluency, and reading speed were all diminished in comparison to controls, independent of scores for affective disorder and fatigue. No overall difference in outcome was seen between patients in long-term remission for Cushing's disease and cortisol-producing adrenal adenoma. CONCLUSION: Patients with CS in remission have impaired cognitive function that cannot be explained by the coexistence of affective disorder or chronic fatigue. The pattern of cognitive and attentional deficits suggests a more global involvement of the brain function than has previously been suggested.


Subject(s)
Adrenal Cortex Neoplasms/complications , Adrenal Cortex Neoplasms/psychology , Adrenocortical Adenoma/complications , Adrenocortical Adenoma/psychology , Attention Deficit Disorder with Hyperactivity/etiology , Attention Deficit Disorder with Hyperactivity/psychology , Cognition Disorders/etiology , Cognition Disorders/psychology , Hydrocortisone/metabolism , Pituitary ACTH Hypersecretion/complications , Pituitary ACTH Hypersecretion/psychology , Adrenal Cortex Neoplasms/metabolism , Adrenalectomy , Adrenocortical Adenoma/metabolism , Adult , Age of Onset , Aged , Arousal/physiology , Case-Control Studies , Corticotropin-Releasing Hormone , Cross-Sectional Studies , Dexamethasone , Fatigue/etiology , Fatigue/psychology , Female , Hormones/blood , Humans , Male , Middle Aged , Neuropsychological Tests , Social Class
5.
Int. braz. j. urol ; 41(6): 1108-1115, Nov.-Dec. 2015. tab, graf
Article in English | LILACS | ID: lil-769753

ABSTRACT

Purpose: To analyze the association of marital status and survival of patients with ACC using a population-based database. Material and Methods: Patients with ACC were abstracted from the Surveillance Epidemiology and End Results (SEER) database from 1988-2010 (n=1271). Variables included marital status (married vs single/divorced/widowed (SDW)), gender, age, race, tumor (T) and node (N) classification, receipt of surgery, and SEER stage. Statistical analysis was performed using Cox proportional hazard models to generate hazard ratios and 95% confidence intervals. Results: There were 728 (57.3%) females and median age was 56 years (IQR 44-66). Patients who were alive were more frequently married (65.6% vs 61.6%, p=0.008), female (61.1% vs 58.0%, p=0.001), younger (median 51 vs 57 years, p=0.0001), submitted to adrenalectomy (88.6% vs 63.8%, p<0.0001), and more favorable SEER stage (localized-64.9% vs 29.9%; regional–25.1% vs 30.1%; distant 4.8% vs 31.5%, p<0.0001) compared to patients dead of disease (DOD). On multivariable analysis, factors significantly associated with all-cause mortality were SDW status (HR 1.28, 95% CI 1.091.51), age, non-operative management, and N+ disease. Risk factors for disease-specific mortality included SDW status (HR 1.30, 95% CI 1.07-1.56), age, non-operative management, T-classification, and N+ disease. Conclusions: Marital status is significantly associated with survival in patients with ACC. Our results suggest that the decreased survival seen among SDW individuals highlights an area for further research and needed intervention to reduce disparity.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Adrenal Cortex Neoplasms/mortality , Adrenocortical Carcinoma/mortality , Marital Status/statistics & numerical data , Adrenal Cortex Neoplasms/psychology , Adrenocortical Carcinoma/psychology , Kaplan-Meier Estimate , Proportional Hazards Models , Risk Factors , SEER Program , Sex Distribution , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL